Evidence map›Paper›PMID 19373869›Full record

ArticleJournal of cellular physiology2009

Modulation of HSP27 alters hypoxia-induced endothelial permeability and related signaling pathways.

Tiegang Liu, Oscar E Guevara, Rod R Warburton, Nicholas S Hill, Matthias Gaestel, Usamah S Kayyali

Open access · greenAbstract read
In one paragraph

Article in Journal of cellular physiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Hypoxia-induced hyperpermeability of rat glomerular endothelial cells involves HIF-2α mediated changes in the expression of occludin and ZO-1.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2018
    Article
  6. Article
  7. Article
  8. Anthrax lethal toxin-induced lung injury and treatment by activating MK2.Journal of applied physiology (Bethesda, Md. : 1985) · 2015
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Role of src-suppressed C kinase substrate in rat pulmonary microvascular endothelial hyperpermeability stimulated by inflammatory cytokines.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2010
    Article
  15. Regulation of vimentin intermediate filaments in endothelial cells by hypoxia.American journal of physiology. Cell physiology · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Tiegang LiuTufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02111, USA.
Oscar E Guevara
Rod R Warburton
Nicholas S Hill
Matthias Gaestel
Usamah S Kayyali
Tufts Medical Center · USTufts University · USMedizinische Hochschule Hannover · DE

Funding

Hypoxia-induced Endothelial Barrier DysfunctionR01HL079320 · NHLBI · TUFTS MEDICAL CENTER · PI KAYYALI, USAMAH S · 2005 to 2009
$1.9M
NHLBI NIH HHS HL-79320NHLBI NIH HHS R01 HL079320
6 · The paper itself

Abstract

This manuscript describes how the permeability of pulmonary artery microvascular endothelial cell (RPMEC) monolayer is elevated by hypoxia and the role played by HSP27 phosphorylation. p38 MAP kinase activation leading to HSP27 phosphorylation was previously shown by our laboratory to alter the actin cytoskeleton and tethering properties of RPMEC. This effect was independent of hypoxia-induced contractility which was ROCK-dependent rather than HSP27-dependent. Results described here show that increased HSP27 phosphorylation not only does not underlie hypoxia-induced permeability, but may actually augment the endothelial barrier. Hypoxia causes gap formation between RPMEC and increases MLC2 phosphorylation. The phosphorylation of MYPT1, which inhibits MLC2 phosphatase, is also increased in hypoxia. In addition, FAK phosphorylation, which alters focal adhesion signaling, is increased in hypoxia. Overexpressing phosphomimicking HSP27 (pmHSP27), which induces significant actin stress fiber formation, surprisingly renders RPMEC resistant to hypoxia- or TGFbeta-induced permeability. siRNA against pmHSP27 reverses the increased actin stress fiber formation in pmHSP27-overexpressing cells, and disrupting actin stress fibers in pmHSP27-overexpressing RPMEC renders them more susceptible to hypoxia. Finally, hypoxia-induced gap formation, as well as phosphorylation of MLC2, MYPT1 and FAK are almost abolished by overexpressing pmHSP27 in RPMEC. These effects of pmHSP27 overexpression might represent decreased cytoskeletal plasticity and increased tethering which counteracts permeability-inducing contractility. Thus hypoxia activates two pathways one leading to contractility and increased permeability, the other leading to actin stress fibers, stronger adhesion, and reduced permeability. Altering HSP27 phosphorylation, which tips the balance towards decreased permeability, might be targeted in managing endothelial barrier dysfunction.

Indexed as

Capillary PermeabilitySignal TransductionAnimalsCardiac MyosinsCell HypoxiaCells, CulturedEndothelial CellsFocal Adhesion Kinase 1Gap JunctionsHeat-Shock ProteinsHSP27 Heat-Shock ProteinsMolecular ChaperonesMutationMyosin Light Chainsp38 Mitogen-Activated Protein KinasesPhosphorylationCardiac MyosinsFocal Adhesion Kinase 1Heat-Shock ProteinsHSP27 Heat-Shock ProteinsHSPB1 protein, humanHspb1 protein, ratMolecular Chaperonesmyosin light chain 2Myosin Light Chainsp38 Mitogen-Activated Protein KinasesPpp1r12a protein, ratProtein Phosphatase 1Ptk2 protein, ratrho-Associated KinasesTransforming Growth Factor beta

Identifiers

PMID19373869
PMCPMC2891512
OpenAlexW2048387066

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.